Presentation_1_TNF-α-Producing Cryptococcus neoformans Exerts Protective Effects on Host Defenses in Murine Pulmonary Cryptococcosis.pdf
Tumor necrosis factor alpha (TNF-α) plays a critical role in the control of cryptococcal infection, and its insufficiency promotes cryptococcal persistence. To explore the therapeutic potential of TNF-α supplementation as a booster of host anti-cryptococcal responses, we engineered a C. neoformans strain expressing murine TNF-α. Using a murine model of pulmonary cryptococcosis, we demonstrated that TNF-α-producing C. neoformans strain enhances protective elements of host response including preferential T-cell accumulation and improved Th1/Th2 cytokine balance, diminished pulmonary eosinophilia and alternative activation of lung macrophages at the adaptive phase of infection compared to wild type strain-infected mice. Furthermore, TNF-α expression by C. neoformans enhanced the fungicidal activity of macrophages in vitro. Finally, mice infected with the TNF-α-producing C. neoformans strain showed improved fungal control and considerably prolonged survival compared to wild type strain-infected mice, but could not induce sterilizing immunity. Taken together, our results support that TNF-α expression by an engineered C. neoformans strain while insufficient to drive complete immune protection, strongly enhanced protective responses during primary cryptococcal infection.
History
References
- https://doi.org//10.1016/S1473-3099(17)30243-8
- https://doi.org//10.2217/fmb.10.93
- https://doi.org//10.1016/j.fgb.2014.10.017
- https://doi.org//10.1038/nrneurol.2016.167
- https://doi.org//10.1086/507895
- https://doi.org//10.1086/649858
- https://doi.org//10.1016/j.jmii.2010.08.011
- https://doi.org//10.4172/2155-6113.S3-003
- https://doi.org//10.1371/journal.pone.0056269
- https://doi.org//10.2217/fmb.14.132
- https://doi.org//10.2353/ajpath.2009.090530
- https://doi.org//10.3390/jof3040064
- https://doi.org//10.1371/journal.ppat.1004701
- https://doi.org//10.3390/jof3030035
- https://doi.org//10.1128/IAI.70.6.2959-2964.2002
- https://doi.org//10.1128/IAI.73.1.39-49.2005
- https://doi.org//10.1002/path.2287
- https://doi.org//10.1016/S0025-6196(11)60839-2
- https://doi.org//10.1002/art.11301
- https://doi.org//10.1128/IAI.00274-06
- https://doi.org//10.1128/jb.175.5.1405-1411.1993
- https://doi.org//10.1371/journal.pone.0153219
- https://doi.org//10.1371/journal.pone.0122916
- https://doi.org//10.3791/57171
- https://doi.org//10.4049/jimmunol.1700057
- https://doi.org//10.1128/mBio.00264-13
- https://doi.org//10.3389/fimmu.2017.01231
- https://doi.org//10.1046/j.1365-2249.1996.d01-870.x
- https://doi.org//10.1128/mBio.00510-16
- https://doi.org//10.1128/IAI.00176-07
- https://doi.org//10.1371/journal.pone.0047853
- https://doi.org//10.2353/ajpath.2009.080673
- https://doi.org//10.1038/ni.3123
- https://doi.org//10.1128/AAC.38.3.460
Usage metrics
Read the peer-reviewed publication
Categories
- Transplantation Immunology
- Tumour Immunology
- Immunology not elsewhere classified
- Immunology
- Veterinary Immunology
- Animal Immunology
- Genetic Immunology
- Applied Immunology (incl. Antibody Engineering, Xenotransplantation and T-cell Therapies)
- Autoimmunity
- Cellular Immunology
- Humoural Immunology and Immunochemistry
- Immunogenetics (incl. Genetic Immunology)
- Innate Immunity